A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
Phase 2
220
about 1.2 years
18–65
2 sites in AZ, NE
What this study is about
This trial is testing how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of it is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 trial treatments in this trial, participants will get either NNC0662-0419, the treatment being tested or placebo, a treatment that has no active medicine in it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take NNC0662-0419
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Part A: Number of treatment-emergent adverse events (TEAE), Part B: Relative change in body weight
Secondary: Part A: AUC; the area under the NNC0662-0419 plasma concentration-time curve, Part A: Change in body weight, Part A: Cmax; the maximum plasma concentration of NNC0662-0419, Part A: Relative change in body weight, Part B: Body weight reduction greater than or equal to (≥) 5% (Yes/No), Part B: Body weight reduction ≥ 10% (Yes/No), Part B: Body weight reduction ≥ 15% (Yes/No), Part B: Body weight reduction ≥ 20% (Yes/No)
Endocrinology